ESC 365 - Efficacy of pulmonary hypertension-targeted drugs for chronic thromboembolic pulmonary hypertension after percutaneous transluminal pulmonary angioplasty

ESC Premium Access

Efficacy of pulmonary hypertension-targeted drugs for chronic thromboembolic pulmonary hypertension after percutaneous transluminal pulmonary angioplasty

Session: Poster session 3 - Chronic thromboembolic pulmonary hypertension

Topic: Chronic pulmonary hypertension

Speaker: Doctor T. Inami (Tokyo, JP)

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Doctor Takumi Inami

Kyorin University, Tokyo (Japan)

0 follower

18 more presentations in this session

Exacerbated pulmonary hypertension and ventilation perfusion mismatch during exercise in a swine model of chronic thromboembolic pulmonary hypertension.

Speaker: Professor D. Merkus (Munich, DE)

Survival benefit improvement of Pulmonary Endarterectomy with experience gained in a national expert center

Speaker: Doctor I. Hernandez Gonzalez (Valladolid, ES)

Riociguat as a bridge therapy for balloon pulmonary angioplasty in patients with severe chronic thromboembolic pulmonary hypertension

Speaker: Doctor J. Ueda (Osaka, JP)

Is pressure wire useful to predict reperfusion pulmonary edema after balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension?

Speaker: Doctor I. Hernandez Gonzalez (Valladolid, ES)

Replacement sildenafil by riociugat in patients with inoperable or persistent chronic thromboembolic pulmonary hypertension improves exercise capacity and hemodynamics

Speaker: Doctor S. Darocha (Otwock, PL)

Access the full session

Poster session 3 - Chronic thromboembolic pulmonary hypertension

Speakers: Doctor T. Inami, Professor D. Merkus, Doctor I. Hernandez Gonzalez, Doctor J. Ueda, Doctor I. Hernandez Gonzalez...

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources